title: NICE guidelines on antidepressants.
authors.forename: R Hamish
authors.initials: RH
authors.lastname: McAllister-Williams
authors.forename: Karin
authors.initials: K
authors.lastname: Foran
authors.forename: Steven
authors.initials: S
authors.lastname: Forrest
authors.forename: Graham
authors.initials: G
authors.lastname: Ingram
authors.forename: Lindsay
authors.initials: L
authors.lastname: McMahon
authors.forename: Michelle
authors.initials: M
authors.lastname: Taylor
authors.forename: Madhuri
authors.initials: M
authors.lastname: Rajwal
authors.forename: Lenny
authors.initials: L
authors.lastname: Cornwall
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects*; D003511:Cyclohexanols / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy*; D062787:Drug Overdose / Q000517:prevention & control; D005194:Family Practice / Q000592:standards; D019983:Guideline Adherence; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D000069470:Venlafaxine Hydrochloride
chemical_list: D000928:Antidepressive Agents; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride